D. Baldwin (Nottingham, United Kingdom), J. Chorostowska-Wynimko (Warszawa, Poland), N. Kanellakis (Patras, Greece), A. Olland (Strasbourg, France)
Diagnosis and surveillance of pulmonary nodules; the magic world of ‘incidentalomas’ G. Hardavella (London, United Kingdom)
| |
Role of Fibre optic Bronchoscopy in excluding malignancy in patients with haemoptysis following normal CT Thorax M. Thirumaran (Wakefield, United Kingdom)
| |
Diagnostic efficacy and safety of navigational bronchoscopy (NB) in the investigation of challenging lung lesions. a. khan (London, United Kingdom)
| |
Two rare presentations of rare endobronchial leiomyoma from a single centre. R. Swarnakar (Nagpur (Maharashtra), India)
| |
Three distinct clinical presentations of the diffuse idiopathic pulmonary neuroendocrine cell hyperplasia A. Frille (Leipzig, Germany)
| |
Usefulness of F-18 FDG PET/CT to identify metastatic mediastinal lymph node in NSCLC patients with bilateral benign mediastinal lymph node hyperplasia Y. Kim (Yangsan city, Kyeongsang Nam-do, Republic of Korea)
| |
A totally Positron Emission Tomography (PET) negative lung cancer V. Gallo (Rivoli, TO, Italy)
| |
Endobronchial ultrasound-transbronchial needle aspiration and video-assisted mediastinoscopic lymphadenectomy in staging of lung cancer> E. Prina (Canzo, Italy)
| |
Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial). G. Hardavella (London, United Kingdom)
| |
Microwave ablation of malignant lung lesions;safety and efficacy – the King’s experience F. McCaughan (CAMBRIDGE, United Kingdom)
| |
Are older patients at increased risk of adverse events? Safety and outcome of transthoracic needle aspiration biopsy in patients 70-79 vs. =80 years suspected of having lung cancer. U. Bodtger (Holmegaard, Denmark)
| |
Use of M.E.S.S.I.A. software in mediastinal staging of NSCLC L. Mancino (Spinea, Italy)
| |
Systemic inflamation and prognosis in lung cancer stage I-II F. Verdu Rivera (Spain)
| |
Physical activity as a predictor of postoperative complications among patients undergoing lung cancer surgery N. Fouz Rosón (Barcelona, Spain)
| |
Factors associated with delayed recovery to predicted FEV1 calculated with perfusion scan in non-small-cell lung cancer patients after lobectomy H. Kim (Seoul, Republic of Korea)
| |
Adjuvant chemotherapy uptake and survival of patients with NSCLC after complete resection: Single institution/single area experience. V. Kolek (Olomouc, Czech Republic)
| |
Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience P. Akin Kabalak (Ankara, Turkey)
| |
Early recurrence in complete resected non-small cell lung cancer patients E. de Sousa Antunes Dias Padrão (Braga, Portugal)
| |
Long-term survival after surgical resection for non-small cell lung cancer A. Bugge (Oslo, Norway)
| |